Amundi - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Amundi ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q4 2022$41,976
-70.8%
9,454
-64.6%
0.00%
Q3 2022$144,000
+22.0%
26,7140.0%0.00%
Q2 2022$118,00026,7140.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$6,697,0000.99%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$939,0000.34%
Winning Points Advisors, LLC 43,958$428,0000.31%
HARBOURVEST PARTNERS LLC 335,709$3,270,0000.31%
Clearwater Capital Advisors, LLC 147,891$1,440,0000.17%
SHEETS SMITH WEALTH MANAGEMENT 121,923$1,188,0000.16%
Jump Financial, LLC 129,600$1,262,0000.09%
OCCUDO QUANTITATIVE STRATEGIES LP 75,022$731,0000.09%
ClariVest Asset Management LLC 206,332$2,010,0000.06%
Virtus ETF Advisers LLC 14,244$139,0000.06%
View complete list of IMMUNITYBIO INC shareholders